Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frewitt is a Swiss process-equipment company that develops and manufactures milling, sieving, homogenizing, deagglomerating, conveying, dosing, and filling systems for powders, granulates, and suspensions. Founded in 1946, the company primarily serves pharmaceutical customers, while also supplying fine chemical, food, energy, and battery markets. In life sciences, Frewitt provides GMP-oriented particle-size reduction and powder-handling equipment used in the manufacture of tablets, capsules, granulates, and other drug products, including containment-focused and lab-to-production scale solutions. Its product portfolio includes modular milling platforms such as FlexMill and FlexMill-Lab, as well as turnkey installations and after-sales services. Frewitt is best characterized as a commercial equipment and technology supplier to the pharma manufacturing value chain rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frewitt.